IDNA – iShares Genomics Immunology and Healthcare ETF
iShares Genomics Immunology and Healthcare ETF (IDNA) is a Health ETF, issued by iShares, $321M in assets, 0.47% expense ratio.
Returns as of Oct 23, 2026: 1 week +0.9%, 1 year +66.1%.
Tracks index of companies benefiting from genomics, immunology, and bioengineering growth. Invests in developed and emerging markets.
Top holdings
- MRNA – Moderna Inc, 11.6%
- TWST – Twist Bioscience Corp, 5.5%
- IOVA – Iovance Biotherapeutics Inc, 4.7%
- GMAB – Genmab A/S, 4.4%
- 4502 – Takeda Pharmaceutical Co. Ltd., 3.9%
- REGN – Regeneron Pharmaceuticals Inc, 3.7%
- EXEL – Exelixis Inc, 3.6%
- RVMD – Revolution Medicines Inc, 3.6%
- VRTX – Vertex Pharmaceuticals Inc, 3.5%
- MRK – Merck & Company Inc, 3.5%
- CAI – Caris Life Sciences, Inc. Common Stock, 3.4%
- ROP – Roche Holding AG, 3.3%
- BAYN – Bayer AG NA, 3.3%
- INCY – Incyte Corporation, 3.1%
- GSK – GSK plc, 2.9%
- BNTX – BioNTech SE, 2.8%
- IBRX – Immunitybio Inc, 2.8%
- IPN – Ipsen SA, 2.6%
- IDYA – Ideaya Biosciences Inc, 2.6%
- SAN – Sanofi SA, 2.5%
- ABCL – Abcellera Biologics Inc, 2.4%
- 4528 – Ono Pharmaceutical Ltd, 1.7%
- RCUS – Arcus Biosciences Inc, 1.5%
- NVAX – Novavax Inc, 1.5%
- CRSP – Crispr Therapeutics AG, 1.3%